失乐园在线观看 I 日韩精品久久一区二区三区 I 国产福利影视 I 17婷婷久久www I 91青青草视频 I 国产激情一区 I sm成人免费看www软件 I 懂色av网站 I 国模私拍视频一区 I 91视频完整版 I 国产 中文 字幕 日韩 在线 I 欧美tv xtime I 国产偷在线 I 97超频在线观看 I 国产馆在线播放 I 成人av在线网站 I 99热香蕉 I 伊人色综合久久天天人手人婷

myocardial infarction is myocardial cell death caused by myocardial ischemia and hypoxia, which is one of the main causes of death of cardiovascular diseases.

Current treatments are mainly drug therapy, thrombolysis, stent placement and bypass grafting, but these methods cannot fundamentally repair the damaged heart and restore the heart function. Engineered stem cells refer to the stem cells cultured, expanded, differentiated or modified in vitro, and have certain biological characteristics and functions. The principle of engineered stem cells for the diagnosis and treatment of myocardial infarction is to transplant to the damaged heart, promote myocyte regeneration, blood vessel regeneration, suppression of inflammation, and immune regulation, so as to improve cardiac remodeling and function. The methods used by engineering stem cells for the diagnosis and treatment of myocardial infarction mainly include direct injection, coronary perfusion and stent implantation, among which direct injection is the most simple, but there are also problems of low cell survival rate and uneven distribution. The effect of engineered stem cells for the diagnosis and treatment of myocardial infarction is still controversial. Different animal models and clinical trials have shown inconsistent results, which may be related to the cell type, source, dose, route, timing and other factors. The challenges of engineered stem cells for the diagnosis and treatment of myocardial infarction mainly include improving the quality and quantity of cells, optimizing the conditions and methods of transplantation, solving the risks of xenograft rejection and tumor formation, and monitoring the effect and safety after transplantation.
Combined with biomimetic strategy to modify exosomes, realize targeted therapy of cardiac repair, using engineered exosomes to promote myocardial vascularization and vascularization and functional recovery after myocardial infarction.